# PVLA (Palvella Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Palvella Therapeutics, Inc. reported $239.4M in total assets and a net loss of $74.99M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/PVLA
- Markdown: https://convexityos.com/fundamentals/PVLA.md
- SEC CIK: 0001583648
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:22 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001583648&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$70.29M | Operating profit |
| Net Income | FY 2025 | -$74.99M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$5.16 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $236.7M | Total debt: $485K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $42.81M | $25.90M | $31.42M | $29.32M | $46.28M | $29.10M | $25.27M | $5.83M |
| Research & Development | $22.84M | $8.15M | $8.79M | $52.98M | $66.66M | $46.53M | $55.00M | $41.49M | $22.29M | $19.70M |
| Total Operating Expenses | $38.60M | $14.10M | $11.87M | $69.38M | $83.25M | $63.24M | $73.44M | $59.93M | $39.87M | $28.59M |
| **Operating Income** | -$38.60M | -$14.10M | -$11.87M | -$43.47M | -$51.83M | -$33.92M | -$27.16M | -$30.83M | -$14.59M | -$22.76M |
| **EBITDA** | -- | -- | -$9.96M | -$40.70M | -$49.37M | -$31.82M | -$26.56M | -$30.26M | -$14.22M | -$22.40M |
| Interest Expense | $0 | $430K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$41.72M | -$17.43M | $18.69M | -$33.28M | -$45.74M | -$37.07M | -$25.47M | -$27.07M | -$16.54M | -$22.64M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $164K | $0 | -$312K | $1.10M | $162K |
| **Net Income** | -$41.72M | -$17.43M | $18.69M | -$33.28M | -$45.74M | -$37.23M | -$25.47M | -$26.75M | -$17.65M | -$22.80M |
| Basic EPS | -$3.71 | -$7.83 | $2.19 | -$36.00 | -$56.80 | -$54.40 | -$44.80 | -$40.00 | -$32.00 | -$44.00 |
| **Diluted EPS** | -$3.71 | -$7.83 | $2.17 | -- | -$56.80 | -$54.40 | -$44.80 | -$40.00 | -$32.00 | -$44.00 |
| Basic Shares Outstanding | 11.3M | 2.2M | 1.8M | 927.1K | 806.8K | 681.0K | 632.8K | 663.5K | 549.1K | 521.4K |
| Diluted Shares Outstanding | 11.3M | 2.2M | 1.8M | -- | 806.8K | 681.0K | 632.8K | 663.5K | 549.1K | 521.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $10.82M | $12.47M | $9.33M | $7.12M | $6.53M | $5.12M | $4.07M | $2.54M |
| Total Operating Expenses | $22.73M | $21.41M | $14.86M | $11.30M | $10.18M | $9.25M | $7.87M | $4.37M |
| **Operating Income** | -$22.73M | -$21.41M | -$14.86M | -$11.30M | -$10.18M | -$9.25M | -$7.87M | -$4.37M |
| Interest Expense | -- | -- | -- | -- | $0 | $0 | -- | -- |
| Income Before Tax | -$24.64M | -$21.87M | -$15.77M | -$12.71M | -$11.35M | -$9.47M | -$8.19M | -$3.95M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$24.64M | -$21.87M | -$15.77M | -$12.71M | -$11.35M | -$9.47M | -$8.19M | -$3.95M |
| Basic EPS | -$1.70 | -$1.52 | -$1.20 | -- | -$1.03 | -$0.86 | -$0.74 | -- |
| **Diluted EPS** | -$1.70 | -$1.52 | -$1.20 | -- | -$1.03 | -$0.86 | -$0.74 | -- |
| Basic Shares Outstanding | 14.5M | 14.4M | 13.1M | -- | 11.1M | 11.1M | 11.0M | -- |
| Diluted Shares Outstanding | 14.5M | 14.4M | 13.1M | -- | 11.1M | 11.1M | 11.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $57.98M | $83.60M | $7.35M | $38.63M | $117.8M | $70.44M | $62.26M | -- | $74.87M | $37.88M |
| Short-Term Investments | $0 | -- | $8.97M | $20.53M | $0 | $0 | $41.89M | -- | $53.24M | $34.75M |
| **Cash & Short-Term Investments** | $57.98M | $83.60M | $26.40M | $59.20M | $117.8M | $70.44M | $104.2M | -- | $128.1M | $72.63M |
| Accounts Receivable, Net | $0 | $358K | $0 | $5.81M | $3.31M | $1.71M | $6.79M | -- | $2.70M | $15.55M |
| **Total Current Assets** | $58.99M | $88.23M | $7.55M | $73.42M | $127.6M | $75.72M | $115.0M | -- | $135.4M | $89.79M |
| Property, Plant & Equipment, Net | -- | -- | $0 | $16.99M | $19.12M | $22.05M | $19.50M | -- | $5.05M | $4.03M |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $9.92M |
| Other Non-Current Assets | -- | -- | $0 | $1.37M | $2.90M | $3.31M | $3.15M | $2.03M | $910K | $130K |
| **Total Non-Current Assets** | $572K | $0 | $0 | $22.07M | $25.93M | $29.29M | $26.08M | -- | $5.96M | $14.09M |
| **Total Assets** | $59.56M | $88.23M | $7.55M | $95.49M | $153.6M | $105.0M | $141.1M | $143.2M | $141.3M | $103.9M |
| Accounts Payable | $4.59M | $4.59M | $936K | $4.15M | $8.61M | $1.79M | $5.80M | -- | $3.35M | $2.45M |
| Deferred Revenue (Current) | -- | -- | $0 | $20.82M | $25.12M | $12.63M | $11.26M | -- | $35.61M | $37.15M |
| Other Current Liabilities | $705K | $1.19M | $169K | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $11.34M | $12.04M | $2.36M | $36.58M | $50.56M | $22.14M | $27.00M | -- | $48.08M | $45.77M |
| Deferred Revenue (Non-Current) | -- | -- | $0 | $18.73M | $38.40M | $35.90M | $47.26M | $56.78M | $53.30M | $46.54M |
| Other Non-Current Liabilities | -- | -- | -- | $0 | $0 | $6.0K | $0 | -- | $27K | $37K |
| **Total Non-Current Liabilities** | $20.23M | $13.59M | $9.07M | $30.98M | $52.24M | $51.84M | $62.74M | -- | $53.33M | $46.58M |
| **Total Liabilities** | $31.58M | $25.63M | $11.43M | $67.56M | $102.8M | $73.98M | $89.75M | $104.9M | $101.4M | $92.35M |
| **Total Debt (incl. Leases)** | $633K | -- | -- | $13.10M | $14.89M | $16.96M | $16.22M | $903K | -- | -- |
| Common Stock | $12K | $11K | $0 | $74K | $72K | $56K | $55K | -- | $54K | $45K |
| Retained Earnings | -$135.4M | -$93.73M | -$76.30M | -$290.4M | -$257.1M | -$211.4M | -$174.2M | -$148.7M | -$147.1M | -$120.3M |
| Accumulated Other Comp. Income | $83K | $3.0K | $0 | -$254K | $829K | -$295K | -$2.00M | -- | -$2.98M | -$4.70M |
| **Total Stockholders' Equity** | $27.98M | $62.61M | -$74.48M | -$93.78M | $50.76M | $31.03M | $51.35M | $38.29M | $39.94M | $11.52M |
| Total Equity | $27.98M | $62.61M | -$74.48M | -$93.78M | $50.76M | $31.03M | $51.35M | $38.29M | $39.94M | $11.52M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $193.3M | $187.8M | $206.4M | $57.98M | $63.57M | $70.43M | $75.63M | $83.60M |
| Short-Term Investments | $43.38M | $62.78M | $55.46M | $0 | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $236.7M | $250.6M | $261.9M | $57.98M | $63.57M | $70.43M | $75.63M | $83.60M |
| Accounts Receivable, Net | -- | -- | -- | $0 | $0 | $0 | $0 | $358K |
| **Total Current Assets** | $239.0M | $253.0M | $263.2M | $58.99M | $66.94M | $73.75M | $79.44M | $88.23M |
| **Total Non-Current Assets** | $435K | $482K | $528K | $572K | $0 | $0 | $0 | $0 |
| **Total Assets** | $239.4M | $253.5M | $263.8M | $59.56M | $66.94M | $73.75M | $79.44M | $88.23M |
| Accounts Payable | $5.16M | $6.79M | $5.44M | $4.59M | $3.48M | $4.56M | $4.44M | $4.59M |
| Other Current Liabilities | $1.34M | $1.24M | $960K | $705K | $1.05M | $925K | $825K | $1.19M |
| **Total Current Liabilities** | $14.93M | $11.95M | $9.12M | $11.34M | $10.31M | $9.62M | $8.98M | $12.04M |
| **Total Non-Current Liabilities** | $26.55M | $24.70M | $22.33M | $20.23M | $17.94M | $16.35M | $14.88M | $13.59M |
| **Total Liabilities** | $41.48M | $36.64M | $31.45M | $31.58M | $28.25M | $25.97M | $23.86M | $25.63M |
| **Total Debt (incl. Leases)** | $485K | $535K | $584K | $633K | -- | -- | -- | -- |
| Common Stock | $15K | $14K | $14K | $12K | $11K | $11K | $11K | $11K |
| Retained Earnings | -$197.7M | -$173.1M | -$151.2M | -$135.4M | -$122.7M | -$111.4M | -$101.9M | -$93.73M |
| Accumulated Other Comp. Income | $56K | $89K | $95K | $83K | $104K | -$111K | -$3.0K | $3.0K |
| **Total Stockholders' Equity** | $197.9M | $216.9M | $232.3M | $27.98M | $38.68M | $47.78M | $55.58M | $62.61M |
| Total Equity | $197.9M | $216.9M | $232.3M | $27.98M | $38.68M | $47.78M | $55.58M | $62.61M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$41.72M | -$17.43M | $18.69M | -$33.28M | -$45.74M | -$37.23M | -$25.47M | -$26.75M | -$17.65M | -$22.80M |
| Depreciation & Amortization | -- | -- | $1.90M | $2.77M | $2.46M | $2.10M | $600K | $570K | $369K | $361K |
| Stock-Based Compensation | $6.40M | $830K | $603K | $4.40M | $5.21M | $5.09M | $5.37M | $4.94M | $3.05M | $1.91M |
| Change in Receivables | $387K | $0 | $5.31M | -$2.62M | -$1.81M | $5.34M | -$4.05M | $12.51M | -$14.47M | -$59K |
| Change in Payables | $1.26M | $2.24M | -$2.25M | -$4.21M | $7.05M | -$4.35M | $1.26M | $764K | -$332K | $1.36M |
| **Operating Cash Flow** | -$25.01M | -$10.84M | -$13.70M | -$59.93M | -$7.66M | -$45.90M | -$52.47M | -$1.07M | $49.75M | -$14.39M |
| Capital Expenditure | -- | -- | -$171K | -$1.04M | -$949K | -$2.73M | -$2.46M | -$1.70M | -$1.95M | -$560K |
| **Free Cash Flow** | -- | -- | -$13.87M | -$60.97M | -$8.61M | -$48.62M | -$54.93M | -$2.76M | $47.80M | -$14.95M |
| Purchases of Investments | -- | -- | -$22.84M | -$48.40M | $0 | -$41.50M | -$59.32M | -$117.6M | -$43.92M | $0 |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | $83.44M | $71.62M | $110.4M | $0 | -- |
| **Investing Cash Flow** | -- | -- | $12.00M | -$21.24M | -$949K | $39.21M | $9.84M | -$8.88M | -$45.88M | -$560K |
| Common Stock Issued | -- | -- | $19.73M | $6.92M | $38.19M | $9.62M | -- | -- | -- | -- |
| **Financing Cash Flow** | -$660K | $87.09M | $5.00M | $7.21M | $59.13M | $10.12M | $32.17M | $48.51M | $4.09M | $15.22M |
| **Net Change in Cash** | -$25.62M | $76.25M | -$8.70M | -$79.13M | $47.33M | $8.18M | -$12.61M | $36.99M | $8.52M | $6.0K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$24.64M | -$21.87M | -$15.77M | -$12.71M | -$11.35M | -$9.47M | -$8.19M | -$3.95M |
| Stock-Based Compensation | $5.42M | $5.16M | $3.38M | $2.08M | $1.79M | $1.43M | $1.09M | $268K |
| Change in Receivables | -- | -- | -- | $29K | $0 | $0 | $358K | $0 |
| Change in Payables | -$1.71M | $1.35M | $851K | $1.16M | -$1.14M | $116K | $1.12M | $43K |
| **Operating Cash Flow** | -$14.43M | -$12.85M | -$10.86M | -$4.93M | -$7.88M | -$5.43M | -$6.77M | -$5.39M |
| Purchases of Investments | -$4.43M | -$15.03M | -$55.44M | -- | $0 | $0 | $0 | -- |
| **Investing Cash Flow** | $19.57M | -$7.03M | -$55.44M | -- | $0 | $0 | $0 | -- |
| Common Stock Issued | $0 | $0 | $230.0M | -- | $0 | $0 | $0 | -- |
| **Financing Cash Flow** | $452K | $1.28M | $214.7M | -$49K | $242K | $349K | -$1.20M | $74.78M |
| **Net Change in Cash** | $5.49M | -$18.59M | $148.4M | -$5.58M | -$6.87M | -$5.19M | -$7.98M | $69.39M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -27.7% | -167.8% | -165.0% | -115.7% | -58.7% | -105.9% | -57.7% | -390.3% |
| **Net Profit Margin** | -- | -- | 43.7% | -128.5% | -145.6% | -127.0% | -55.0% | -91.9% | -69.8% | -391.0% |
| Return on Equity (ROE) | -149.1% | -27.8% | -- | -- | -90.1% | -120.0% | -49.6% | -67.0% | -153.2% | -90.4% |
| Return on Assets (ROA) | -70.0% | -19.8% | 247.6% | -34.8% | -29.8% | -35.5% | -18.1% | -18.9% | -17.0% | -65.0% |
| Current Ratio | 5.20x | 7.33x | 3.20x | 2.01x | 2.52x | 3.42x | 4.26x | 2.82x | 1.96x | 3.90x |
| Quick Ratio | 5.11x | 6.97x | 11.19x | 1.78x | 2.39x | 3.26x | 4.11x | 2.72x | 1.93x | 3.51x |
| Debt to Equity | 0.02x | -- | -- | -- | 0.29x | 0.55x | 0.32x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | +65.3% | -17.6% | +7.1% | -36.6% | +59.0% | +15.1% | +333.5% | +98.9% |
| **Net Income Growth (YoY)** | -- | -193.3% | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -457.5% | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -102.1% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -105.8% | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -44.9% | -39.3% | +248.2% | +531.4% | +136.4% | -47.8% | -- | -- |
| 10Y Revenue / Share Growth | -- | -- | -71.2% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -9106.7% | -- | -- |
| 10Y Net Income / Share Growth | -- | -- | +2258.5% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -37.9% | -28.4% | -21.2% | -149.1% | -85.2% | -59.4% | -41.5% | -27.8% |
| Return on Assets (ROA) | -31.3% | -24.3% | -18.7% | -70.0% | -49.2% | -38.5% | -29.1% | -19.8% |
| Current Ratio | 16.01x | 21.18x | 28.88x | 5.20x | 6.49x | 7.67x | 8.84x | 7.33x |
| Quick Ratio | 15.86x | 20.98x | 28.73x | 5.11x | 6.16x | 7.32x | 8.42x | 6.97x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.02x | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -132.6% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -110.2% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -126.4% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
